NIH-funded research NIH-funded research

Endothelial MEKK3 signaling and vascular remodeling

Official title: The role of endothelial MEKK3 signaling in pathological vascular remodeling

Funded at Oklahoma Medical Research Foundation · NIH-11336058 · Data updated 2026-11-12

A study in people with vascular disease factors aims to understand how blood vessel lining cells sense blood flow and decide when to stay stable or remodel.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOklahoma Medical Research Foundation
NIH-funded
Lab location1 site (Oklahoma City, United States)
Project startFebruary 5, 2021
Project endMarch 31, 2031
Funding year2026
Award (this year)$306,900
NIH project number2P20GM139763-06
Project IDNIH-11336058 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with vascular malformations or related blood vessel conditions who could contribute tissue samples or participate in mechanistic studies.

Less likely to help

People without vascular conditions may not directly benefit, as the work focuses on mechanisms of vessel remodeling.

What this research studies

Endothelial cells sense the forces from blood flow and use signaling pathways to decide whether vessels should stay steady or change shape. This project explores how MEKK3-related signaling controls key factors like KLF2/4 that govern vascular behavior under different flow conditions. By examining the MEKK2/3-p62 complex and its role in shear sensing, researchers hope to clarify why some vessels become malformed. The findings could pave the way for therapies that prevent or correct abnormal vessel remodeling in patients with vascular diseases.

Why it matters

Potential benefit: If successful, this work could lead to new approaches to prevent or treat abnormal blood vessel remodeling in patients with vascular disorders.

How similar studies have gone: Previous work has shown MEKK3-related pathways influence vascular signaling, with ongoing efforts building on these insights.

Where this research is happening

  • Oklahoma Medical Research Foundation
    Oklahoma City, United States
    Active

Researchers

  • Principal investigator: Coon, Brian Gene — Oklahoma Medical Research Foundation
  • Study coordinator: Coon, Brian Gene

Related research

Other NIH-funded projects on the same topics.

  • Understanding how DIS3L2 helps keep RNA in check to help lupus patients

    A physician-scientist team is studying how a watchdog molecule for RNA (DIS3L2) may drive lupus-related immune problems, with the goal of uncovering new paths to treatment.

    NIH research Oklahoma Medical Research Foundation · Oklahoma City, United States · NIH-11630879

  • Stem cell mRNA marks and fat-infiltrated aging muscles

    Researchers are studying how aging changes muscle at the cellular level, including fat and fibrous tissue buildup, to help keep older adults stronger and more mobile.

    NIH research Oklahoma Medical Research Foundation · Oklahoma City, United States · NIH-11593119

  • Tissue research hub for autoimmune diseases to speed up new treatments

    A national program is building a centralized tissue core to study autoimmune diseases like lupus, rheumatoid arthritis, Sjögren’s, and psoriatic conditions using advanced single-cell and spatial analysis.

    NIH research Oklahoma Medical Research Foundation · Oklahoma City, United States · NIH-11590648

  • Roles of mitochondrial transporters SLC25A22 and SLC25A46 in brain health

    This grant studies how two mitochondrial transporters, SLC25A22 and SLC25A46, affect brain metabolism and neurological disorders using fruit-fly models to uncover disease mechanisms.

    NIH research Oklahoma Medical Research Foundation · Oklahoma City, United States · NIH-11515601

  • Colon mucus sugars and how they help keep gut bacteria and the colon healthy

    Researchers are looking at how sugar-coated mucus made by cells in the front part of the colon helps keep gut bacteria balanced and may protect people with ulcerative colitis or pouch inflammation.

    NIH research Oklahoma Medical Research Foundation · Oklahoma City, United States · NIH-11401680

  • Oxidized lipids driving aging-related muscle loss

    This project explores how certain lipid molecules that are damaged or modified over time contribute to muscle weakness and loss in older adults, with the goal of identifying new ways to prevent sarcopenia.

    NIH research Oklahoma Medical Research Foundation · Oklahoma City, United States · NIH-11396249

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.